Introduction: The acute respiratory distress syndrome (ARDS), secondary to viral
pneumonitis, is one of the main causes of high mortality in patients with COVID-19 (novel …

The acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis is one of the
main causes of high mortality in patients with COVID-19 (novel coronavirus disease 2019) …

Summary Activation of C‐X‐C motif chemokine receptor 4 (CXCR4) has been reported to
result in lung protective effects in various experimental models. The effects of …

Summary CCL8 (MCP-2) is a chemoattractive cytokine associated with various immune-
related pathologies. Recent studies show that CCL8 is significantly stimulated during acute …

We compared therapeutic properties of natural and engineered chemokine (CXC motif)
receptor 4 (CXCR4) agonists in a rat acute respiratory distress syndrome (ARDS) model …

Loss of control in the trafficking of immune cells to the inflamed lung tissue contributes to the
pathogenesis of life-threatening acute lung injury (ALI) and its more severe form, acute …

Acute respiratory distress syndrome (ARDS) consists of uncontrolled inflammation that
causes hypoxemia and reduced lung compliance. Since it is a complex process, not all …

Introduction: Alveolar macrophages helps in maintaining the homeostasis in the lungs.
CCL2 and its receptor CCR2 play a role regulating the monocyte and leukocyte trafficking …

Objective Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now a global pandemic. Emerging results indicate a dysregulated immune response. Given …

Results Histology findings revealed that the SB225002-treated group had significantly
milder lung injury compared to the LPS-induced ALI and the PBS-treated control groups …